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Abstract 
A recombinant form of human placental S-adenosylhomocys- 
teine (AdoHcy) hydrolase expressed in E. coli, which was 
inactivated by a type-I mechanism-based inhibitor, has been 
crystallized using the hanging-drop vapour-diffusion technique. 
The crystals grow as fiat plates, with unit-cell dimensions 
a=96.2,  b=173.6, c=142.9A, c t=f l=7=90  °. The crystals 
exhibit the symmetry of space group C222 and diffract to a 
minimum spacing of "-~ 2.0 A resolution at the Cornell High 
Energy Synchrotron Source. On the basis of density calcula- 
tions two monomers of the tetrameric protein are estimated to 
be present in the asymmetric unit (Vm = 2.99 ,~3 Da-l). The self- 
rotation function clearly indicates the location of the non- 
crystallographic twofold axis. 
1. Abbreviations 
AdoHcy hydrolase, S-adenosylhomocysteine hydrolase; 
AdoHcy, S-adenosylhomocysteine; Hcy, homocysteine; Ado, 
adenosine; AdoMet, S-adenosylmethionine; DHCaA, 
( l'R,2'S,3'R)-9-(2',3' dihydroxycyclopentan- l '-yl) adenine. 
2. Introduction 
The enzymatic transfer of a methyl group from S-adenosyl- 
methionine (AdoMet) to an acceptor molecule, i.e. biological 
transmethylation, is a reaction involved in regulating a diverse 
array of physiologically important processes. The activities of 
all AdoMet-dependent methyltransferases are regulated by the 
intracellular level of S-adenosylhomocysteine (AdoHcy), a 
product inhibitor of AdoMet-dependent transmethylations 
(Borchardt, 1980). In all eukaryotic cells, the intracellular level 
of AdoHcy is regulated by the enzyme AdoHcy hydrolase 
(Eloranta & Kajander, 1984; Eloranta, Kajander & Raina, 1982) 
(E.C. 3.3.1.1) which catalyzes the reversible hydrolysis of 
AdoHcy to adenosine (Ado) and homocysteine (Hcy) (de la 
Haba & Cantoni, 1959). AdoHcy hydrolase is a highly 
conserved enzyme, with the human protein sharing --~70% 
amino-acid sequence identity with the enzymes from 
Dictyostelium and Leishmania, two species that are separated 
from humans by over a billion years of evolution (Coulter-Karis 
& Hershfield, 1989; Henderson et al., 1992; Kasir, Aksamit, 
Backlund & Cantoni, 1988). 
AdoHcy hydrolase is a homotetramer of---48 kDa subunits 
(Fujioka & Takata, 1981; Hershfield, Aiyar, Premakumar & 
Small, 1985; Palmer & Abeles, 1979; Richards, Chiang & 
Cantoni, 1978; Ueland, 1982) with one NAD + cofactor bound 
per subunit (Palmer & Abeles, 1976). 
Palmer & Ableles (1976, 1979) have elucidated the 
mechanism by which AdoHcy hydrolase catalyzes the rever- 
sible hydrolysis. In the hydrolytic direction, the first step 
involves the oxidation of the 3' hydroxyl group of AdoHcy by 
the enzyme bound NAD +. This oxidation is followed by the 
elimination of Hcy to give 3'-keto-4',5'-dehydroadenosine. The 
Michael addition of water at the 5' position of this tightly bound 
intermediate to form 3'-ketoadenosine is followed by an 
NADH-dependent reduction to form Ado. AdoHcy hydrolase 
was identified as a high-affinity cytoplasmic adenosine-binding 
protein and the binding of 2'deoxyadenosine and adenosine 
Adenine 
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arabinoside shown to cause its suicide-like inactivation due to 
reduction of the enzyme-bound NAD ÷ (Abeles, Fish & 
Lapinskas, 1982; Hershfield, 1979; Hershfield & Kredich, 
1978; Hershfield, Small, Premakumar, Bagnara & Fetter, 1982). 
Inhibition/inactivation of AdoHcy hydrolase has been impli- 
cated in causing immunodeficiency in humans, fetal hepato- 
toxicity in mice, and with deficiency of adenosine deaminase 
(Hershfield, 1979; Hershfield & Kredich, 1978; Hershfield, 
Kredich, Ownby, Ownby & Buckley, 1979; Kredich & Martin, 
1977; Migchielsen et al., 1995). Deletion of the murine 
AdoHcy hydrolase gene is also associated with early embryonic 
death (Miller et al., 1994). 
Knowledge of the mechanism of the enzyme has been used 
extensively in the design of potent and selective inhibitors of 
AdoHcy hydrolase despite the lack of any detailed information 
about the tertiary structure and the dynamics of the enzyme. 
Indeed, inhibitors of this enzyme have already been shown to 
exhibit antiviral (Liu, Wolfe & Borchardt, 1992; Wolfe & 
Borchardt, 1991), antiparasitic (Bitoni, Baumann, Jarvi, 
McCarthy & McCann, 1990; Henderson et al., 1992) anti- 
arthritic (Wolos, Frondorf & Esser, 1993) and immunosuppres- 
sive properties (Wolos, Frondorf, Babcock, Stripp & Bowlin, 
1993; Wolos et al., 1993). The therapeutic effects of these 
inhibitors can, in most cases, be related to their ability to cause 
an intracellular accumulation of AdoHcy which results in the 
inhibition of the crucial AdoMet-dependent methylation reac- 
tions (Henderson et al., 1992; Liu et al., 1992; Wolfe & 
Borchardt, 1991). The crystallization and preliminary X-ray 
analysis of recombinant human placental AdoHcy hydrolase 
presented in this paper are the first essential steps towards the 
three-dimensional structure determination of this protein and a 
clearer understanding of the mechanism of action of this key 
regulatory enzyme. 
3. Crystallization and data collection 
Earlier attempts to crystallize this enzyme have been unsucess- 
ful and probably failed because conventional purification of the 
protein leads to heterogeneity in the sample with both the 
NAD ÷ (approximately 90%) and NADH (approximately 10%) 
forms of the enzyme present. Therefore, the recombinant 
human placental enzyme, which was purified from cell-free 
extracts of E. coli transformed with the plasmid pPROKcd20 
(Coulter-Karis & Hershfield, 1989, 1990), was used to prepare 
the pure apoenzyme according to previously described 
procedures (Yuan, Yeh, Liu & Borchardt, 1993). This 
apoenzyme was then incubated with NAD ÷ to yield the pure 
NAD + form of the enzyme (Yuan et al., 1993). The NAD + form 
of the AdoHcy hydrolase was then inactivated with 
(l'R,2'S,3'R)-9-(2',3'dihydroxycyclopentan-l'-yl) adenine 
(DHCaA), a type-I mechanism-based inhibitor (Paisley, 
Hasobe & Borchardt, 1989; Wolfe & Borchardt, 1991), forming 
the DHCaA-inactivated enzyme containing one equivalent of 
NADH and one equivalent of 3'-ketoDHCaA bound to each 
subunit of the protein. 
Initial screening for crystallization conditions was performed 
using a sparse-matrix screen (Jancarik & Kim, 1991) at room 
temperature (293K). All crystals were grown using the 
hanging-drop vapour-diffusion technique. 51al of protein 
solution (40-60mgm1-1) were added to 5 ~tl of precipitating 
solution [12%(w/v) PEG 4K, 20%(v/v) isopropanol, 200 mM 
ammonium acetate, 100mM citrate buffer, pH 5.6] on a 
Table 1. Diffraction data statistics 
No. of measured reflections 269482 
No. of independent reflections 56769 
No. of crystals 1 
Resolution (A)* 2.22 
Rmerge t 6.8 (14.1)~ 
Completeness (%) 85.7 (71.2)~ 
Average I/cr(I) 15.6 
* Resolution limit is defined as the limit beyond which fewer than 50% 
of the reflections have I > 3ix(I). Diffraction was observed to at least 
2.0A, resolution. ]'Defined as R = ~ II(k) - (I)1/~-]l(k), where 
l(k) and (I) represent the diffraction intensity values of the individual 
measurements and the corresponding mean values. The summation is 
over all measurements. +Values given in parentheses refer to 
reflections in the outer resolution shell, 2.29-2.22 A. 
siliconized glass coverslip and suspended over a 1 ml reservoir 
containing the same precipitating solution. Some precipitation 
of the protein occurs immediately and is followed by crystal 
growth, with fiat plate-like crystals appearing in approximately 
10-14d. The crystals grow to a maximal size of 
0.8 x 0.5 x 0.1 mm (Fig. 1). Attempts to eliminate the 
precipitation of the protein prior to crystal growth by varying 
the protein and precipitant concentrations failed to yield 
crystals. 
Initially, the crystals were mounted in a quartz capillary and 
data were collected at room temperature on a Siemens 
Xentronics area detector system with a Rigaku RU-200 rotating 
anode. The crystals, however, diffracted weakly to a minimum d 
spacing of approximately 3.5 ,~, and suffered significantly from 
radiation damage. Conditions for freezing the crystals to liquid 
nitrogen temperatures were, therefore, developed. The crystal 
was first transferred to a cryoprotectant solution containing 
l O%(v/v) glycerol, 12%(w/v) PEG 4K, 20%(v/v) isopropanol, 
200 mM ammonium acetate, 100 mM citrate buffer, pH 5.6 for 
approximately 30 min. A rayon CryoLoop (Hampton Research) 
was used to pick up the crystal which was immediately 
transferred into a stream of liquid nitrogen maintained at 100 K. 
The frozen crystals diffracted on the RU-200 X-ray generator to 
a minimum d spacing of--~3.1 ,~. A complete set of native data 
has subsequently been collected at Station A1 at the Cornell 
Fig. 1. Crystal of human AdoHcy hydrolase. The crystal is 
approximately 0.8 × 0.25 × 0.1 mm. 
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High Energy Synchrotron Source to "~2.2 A resolution. The 
data were collected on the ADSC CCD detector with the 
detector set at two different offset heights to measure the low- 
and high-resolution data. The data were processed using the 
program DENZO (Otwinowski, 1993). A total o f  378 
(p-scanning oscillation exposures in steps o f  1.5 ° were recorded. 
A summary  o f  the data-collection statistics is presented in Table 
1. The unit-cell dimensions were found to be a = 9 6 . 2 ,  
b-- 173.6, c--  142.9,~, ~ = f l = 7 - - 9 0 . 0  °. The crystals display 
the symmetry  o f  the space group C222. On the basis o f  density 
calculations, we estimate that two monomers  (Mat-thews 
parameter Vm = 2.99 ,~3 Da-i)  will be present in the asymmetric  
unit (Matthews, 1968). 
A self-rotation function study has been performed using data 
between 10 and 6 ,~, resolution to determine the location o f  the 
non-crystallographic twofold that relates each monomer  in the 
asymmetric  unit. Fig. 2 is the self-rotation function for the 
~:-- 180 ~ section. The unique twofold axis is marked with an 
arrow and lies 23 ° from the a axis. All other peaks on the 
circumference are identical and are related by the crystal- 
lographic twofold axes. The peak is 33.3% of  the origin peak, 
which represents one o f  the crystallographic twofold axes. The 
result o f  this self-rotation study indicate that the tetrameric 
protein has 222 symmetry,  with one o f  the twofold axes parallel 
to the crystallographic c axis, the second twofold is 23 ° from 
the a axis and the third, generated as a consequence o f  the first 
two, is 23: from the b axis. A search for heavy-atom derivatives 
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Fig. 2. Self-rotation function showing the ~¢ = 180 ° scction. ~p angles and 
position of the axes are marked on the circumference. The self- 
rotation function was calculated using a Patterson radius of 35 ]k, an 
inner radius cutoff of 5 ,~ and data between l 0 and 6 A resolution. All 
calculations were performed using the program POLARRFN in the 
CCP4 program package (Collaborative Computational Project, 
Number 4, 1994). The peaks are scaled from 0 to 100%, I00% 
representing the origin peak. Contour lines are plotted for all peaks 
greater than 20% of the origin peak, in intervals of 5%. The unique 
twofold axis is marked with an arrow. 
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